patients

Corcept Receives Complete Response Letter for Relacorilant as a Treatment for Patients with Hypercortisolism

December 31, 2025

REDWOOD CITY, Calif., December 31, 2025–(BUSINESS WIRE)–Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery…

HHealth

December 31, 2025

(NEXSTAR) – Hospitals, nursing homes and other medical facilities are struggling to gain ground on a drug-resistant and…

HHealth care

Billionaire Mark Cuban Wants U.S. Healthcare To Go Back To 1955. Doctors Provide Care, Patients Get A Bill —'And If They Can Afford It, They Pay'

December 24, 2025

Healthcare didn’t become confusing overnight. It got there slowly, buried under paperwork, billing codes, and middlemen most patients…

HHealth

Topical steroid withdrawal community feels sting of NIH turmoil

December 22, 2025

On May 23, 2023, Kelly Barta arrived at the National Institutes of Health to figure out what was…

HHealth

Unpopular diet for cancer patients gets another look

December 22, 2025

Oncologists have been moving away from the notoriously unpopular neutropenic diet. It requires nearly all food to be…

MMedication

Eli Lilly’s pill solves the biggest problem with weight loss

December 21, 2025

Losing weight hasn’t quite been the hardest part of modern obesity treatment. Keeping it off is. That’s exactly…

HHealth

Democratizing the dementia revolution | STAT

December 13, 2025

Below is a lightly edited, AI-generated transcript of the “First Opinion Podcast” interview with Jason Karlawish, who writes…

MMedication

Oh no, Ozempic! Eli Lilly’s New Weight-Loss Drug KOs Rival Treatments

December 12, 2025

How do you swear in Danish? Our AI chatbots are much too polite to help us out here,…

HHealth care

Mass. primary care doctors are switching between rival hospital systems

December 4, 2025

Six primary care providers at a single Mass General Brigham practice are moving to rival Beth Israel Lahey…

MMedication

MannKind Announces U.S. FDA Accepts for Review its Supplemental New Drug Application (sNDA) of FUROSCIX ReadyFlow™ Autoinjector for the Treatment of Edema in Adults with Chronic Heart Failure or Chronic Kidney Disease

December 2, 2025

MannKind If approved, ReadyFlow Autoinjector would deliver an IV-equivalent diuretic dose (subcutaneous furosemide injection 80 mg/ml) in under…

HHealth care

Trump admin claims win as UK bows to pressure on NHS drug spending – POLITICO

December 1, 2025

The new NICE threshold will be £25,000 to £35,000 per quality adjusted life year gained over and above…

MMobile

Mum inspired by son’s health battle to build new app for Kiwis

November 23, 2025

Luca Goodwin, 11, was born with a congenital heart defect and had to undergo three rounds of open-heart…

Corcept Receives Complete Response Letter for Relacorilant as a Treatment for Patients with Hypercortisolism

Superbug hits 27 states: Here’s where the deadly fungus is spreading

Billionaire Mark Cuban Wants U.S. Healthcare To Go Back To 1955. Doctors Provide Care, Patients Get A Bill —’And If They Can Afford It, They Pay’

Topical steroid withdrawal community feels sting of NIH turmoil

Unpopular diet for cancer patients gets another look

Eli Lilly’s pill solves the biggest problem with weight loss

Democratizing the dementia revolution | STAT

Oh no, Ozempic! Eli Lilly’s New Weight-Loss Drug KOs Rival Treatments

Mass. primary care doctors are switching between rival hospital systems

MannKind Announces U.S. FDA Accepts for Review its Supplemental New Drug Application (sNDA) of FUROSCIX ReadyFlow™ Autoinjector for the Treatment of Edema in Adults with Chronic Heart Failure or Chronic Kidney Disease

Trump admin claims win as UK bows to pressure on NHS drug spending – POLITICO

Mum inspired by son’s health battle to build new app for Kiwis